Key points are not available for this paper at this time.
Abstract Purpose: Depressive disorder during early adulthood has been a rising public health concern, potentially further compounded by the COVID-19 pandemic. Using nationally representative large survey samples, this study addressed the knowledge gaps in how COVID-19 affected depressive disorder among U.S. young adults. Methods: The analysis included 348,994 U.S. non-institutionalized young adults aged 18-34 years from the Behavioral Risk Factor Surveillance System for 2018-2022. Changes in the prevalence of diagnosed depressive disorder before and during COVID-19 were assessed by weighted bi-variate analysis using Rao-Scott Chi-Square test, with multivariable logistic regression models fitted to assess the magnitude of depressive disorder before and during COVID-19. Results: Overall, the prevalence of depressive disorder increased by 13.7% (pConclusion: The study findings revealed the importance of recognizing and understanding the most affected groups of young adults during a pandemic like COVID-19, providing essential insights for developing targeted interventions and policies.
Chowdhury et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: